Inmune Bio, Inc.: Form 8-K, filed Jun 30, 2025
Filed with the SEC on Jun 30, 2025 and accepted by EDGAR at Jun 30, 2025, 08:01 ET.
Items reported
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-25-059252. Last ingested by Listed: Oct 29, 2026, 07:41 ET. Listed shows no prices and gives no investment advice.